Spondylitis News and Research

RSS
VIMOVO granted marketing and pricing approval in the UK

VIMOVO granted marketing and pricing approval in the UK

Chronic lower back pain may be linked to axial spondyloarthritis: Research

Chronic lower back pain may be linked to axial spondyloarthritis: Research

Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion

Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Researchers to conduct gene analysis for ankylosing spondylitis

Researchers to conduct gene analysis for ankylosing spondylitis

Merck's SIMPONI anti-TNF therapy now reimbursed in New Brunswick, Nova Scotia and Alberta

Merck's SIMPONI anti-TNF therapy now reimbursed in New Brunswick, Nova Scotia and Alberta

Regeneron second-quarter total revenues increase to $115.9 million

Regeneron second-quarter total revenues increase to $115.9 million

Johnson & Johnson second-quarter sales increase 0.6% to $15.3 billion

Johnson & Johnson second-quarter sales increase 0.6% to $15.3 billion

POZEN receives milestone payment from AstraZeneca for FDA approval of VIMOVO

POZEN receives milestone payment from AstraZeneca for FDA approval of VIMOVO

VIMOVO delayed-release tablets receive FDA approval

VIMOVO delayed-release tablets receive FDA approval

REGN reports net loss of $30.5M for first-quarter 2010

REGN reports net loss of $30.5M for first-quarter 2010

Johnson & Johnson' first-quarter 2010 sales increase 4.0% to $15.6 billion

Johnson & Johnson' first-quarter 2010 sales increase 4.0% to $15.6 billion

Axis Surgical's EC-MOR facilitated real-time visualization of anterior spine column during surgery

Axis Surgical's EC-MOR facilitated real-time visualization of anterior spine column during surgery

Abbott declares quarterly dividend of 40 cents per share

Abbott declares quarterly dividend of 40 cents per share

New breakthroughs in AS genome-wide association study

New breakthroughs in AS genome-wide association study

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Study reveals genomic switches separate autoimmune disorders in different clusters

Study reveals genomic switches separate autoimmune disorders in different clusters

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Schering-Plough announces 2009 third quarter financial results

Schering-Plough announces 2009 third quarter financial results

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials